The store will not work correctly when cookies are disabled.
N-((5-chlorobenzo[b]thiophen-3-yl)methyl)-4-(phenylsulfonyl)thiophene-2-sulfonamide
ID: ALA4533777
PubChem CID: 2811648
Max Phase: Preclinical
Molecular Formula: C19H14ClNO4S4
Molecular Weight: 484.05
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(NCc1csc2ccc(Cl)cc12)c1cc(S(=O)(=O)c2ccccc2)cs1
Standard InChI: InChI=1S/C19H14ClNO4S4/c20-14-6-7-18-17(8-14)13(11-26-18)10-21-29(24,25)19-9-16(12-27-19)28(22,23)15-4-2-1-3-5-15/h1-9,11-12,21H,10H2
Standard InChI Key: MMMCHQRHQOEXDP-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
11.6701 -3.8956 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0868 -4.4830 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.8871 -4.6944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3245 -2.0582 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7411 -2.7748 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.1533 -2.0557 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7785 -3.8165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6035 -3.8165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8602 -3.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1910 -2.5456 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.5259 -3.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1285 -3.3301 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3438 -3.0755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7310 -3.6278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0624 -4.7825 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.8159 -4.4464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5101 -4.1696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9232 -3.4540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5100 -2.7406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6839 -2.7416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2728 -3.4619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6884 -4.1724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2692 -2.0285 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.7512 -5.2376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9295 -5.3184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5931 -6.0708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0774 -6.7398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9019 -6.6513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2345 -5.8988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 2 0
6 5 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 7 2 0
11 5 1 0
5 12 1 0
12 13 1 0
13 14 1 0
14 18 1 0
17 15 1 0
15 16 1 0
16 14 2 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
8 2 1 0
2 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 484.05 | Molecular Weight (Monoisotopic): 482.9494 | AlogP: 4.93 | #Rotatable Bonds: 6 |
Polar Surface Area: 80.31 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.39 | CX Basic pKa: ┄ | CX LogP: 4.91 | CX LogD: 4.87 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.42 | Np Likeness Score: -1.86 |
References
1. (2017) Inhibitors of grb2-associated binding protein 1 (gab1) and methods of treating cancer using the same, |